Tatva Chintan Pharma Chem Ltd

Tatva Chintan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tatva Chintan Pharma Chem Ltd

₹ 825 2.07%
22 Nov - close price
tatvachintan.com BSE: 543321 NSE: TATVA
About

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]

Key Points

Leading Chemical Manufacturer[1]
It is the largest manufacturer of Structure Directing Agents (SDA) for Zeolites in India.

Website BSE NSE
  • Market Cap ₹ 1,929 Cr.
  • Current Price ₹ 825
  • High / Low ₹ 1,651 / 788
  • Stock P/E 109
  • Book Value ₹ 315
  • Dividend Yield 0.24 %
  • ROCE 7.02 %
  • ROE 4.86 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 2.62 times its book value
  • Company has a low return on equity of 12.2% over last 3 years.
  • Dividend payout has been low at 9.93% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -7.15%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
123.62 104.67 98.53 88.40 90.09 120.61 124.51 114.36 96.67 84.21 98.27 105.46 83.49
88.18 80.71 76.54 73.19 78.91 102.70 108.24 93.02 76.43 73.21 82.67 92.85 77.91
Operating Profit 35.44 23.96 21.99 15.21 11.18 17.91 16.27 21.34 20.24 11.00 15.60 12.61 5.58
OPM % 28.67% 22.89% 22.32% 17.21% 12.41% 14.85% 13.07% 18.66% 20.94% 13.06% 15.87% 11.96% 6.68%
3.25 4.57 0.31 1.88 1.55 1.08 -2.74 1.02 0.76 1.21 4.53 1.17 0.38
Interest 1.22 0.99 1.18 1.06 1.36 2.38 3.20 2.93 3.01 0.38 0.21 0.31 0.17
Depreciation 2.06 2.08 2.15 2.33 2.31 2.38 2.53 6.01 6.78 6.58 6.23 6.67 6.81
Profit before tax 35.41 25.46 18.97 13.70 9.06 14.23 7.80 13.42 11.21 5.25 13.69 6.80 -1.02
Tax % 8.47% 10.45% 7.75% 28.47% 21.52% 18.27% -117.31% 29.21% 30.60% 34.10% 29.73% 23.53% -34.31%
32.41 22.81 17.51 9.80 7.11 11.62 16.95 9.50 7.78 3.46 9.61 5.21 -0.66
EPS in Rs 14.62 10.29 7.90 4.42 3.21 5.24 7.65 4.29 3.33 1.48 4.11 2.23 -0.28
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
136 206 263 300 434 424 394 371
113 172 208 234 325 363 325 327
Operating Profit 23 34 55 67 109 61 69 45
OPM % 17% 17% 21% 22% 25% 14% 17% 12%
1 1 1 5 9 2 7 7
Interest 3 4 4 4 5 9 7 1
Depreciation 3 4 5 7 8 10 26 26
Profit before tax 19 27 48 61 104 45 44 25
Tax % 35% 25% 21% 14% 8% -2% 30%
12 21 38 52 96 45 30 18
EPS in Rs 15.30 25.56 47.03 26.02 43.25 20.52 12.97 7.54
Dividend Payout % 0% 0% 0% 19% 5% 10% 15%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: 9%
TTM: -19%
Compounded Profit Growth
10 Years: %
5 Years: 9%
3 Years: -17%
TTM: -64%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -32%
1 Year: -44%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 12%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 8 8 8 20 22 22 23 23
Reserves 51 72 110 146 451 493 714 714
56 77 91 90 120 170 14 15
28 31 41 59 65 74 67 54
Total Liabilities 144 188 249 315 658 759 819 807
57 67 111 120 160 196 427 425
CWIP 10 6 5 10 51 231 77 114
Investments 1 0 0 0 0 0 10 0
76 115 133 185 447 332 305 268
Total Assets 144 188 249 315 658 759 819 807

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
13 7 25 20 20 28 98
-30 -17 -40 -21 -197 -101 -121
7 17 10 -5 235 38 31
Net Cash Flow -10 8 -5 -6 59 -36 8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 77 73 69 110 48 73 65
Inventory Days 148 114 175 173 319 262 320
Days Payable 127 71 87 114 83 52 94
Cash Conversion Cycle 99 116 157 169 283 283 291
Working Capital Days 101 117 104 151 164 168 170
ROCE % 22% 28% 28% 26% 9% 7%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
79.17% 79.17% 79.17% 79.17% 79.17% 79.17% 79.17% 72.02% 72.02% 72.02% 72.02% 72.02%
2.91% 3.05% 3.53% 3.59% 3.74% 3.54% 3.19% 4.40% 4.21% 3.65% 3.37% 3.33%
7.87% 8.13% 10.75% 11.17% 11.52% 11.71% 11.07% 13.78% 13.06% 12.84% 10.64% 6.83%
10.05% 9.65% 6.55% 6.08% 5.58% 5.59% 6.56% 9.79% 10.72% 11.49% 13.97% 17.81%
No. of Shareholders 88,31189,93084,35876,26771,95870,03770,79974,62874,51973,73073,91279,623

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls